« Back
Home /
Laminin peptide CDPGYIGSR (TFA)

Laminin peptide CDPGYIGSR (TFA)

Item no.	HY-P0131A-5mg
Manufacturer	MedChem Express
CASRN	2828432-44-4
Amount	5 mg
Quantity options	10 mg 5 mg
Category	Cell Biology Cell Stainings ECM Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Purity	99.75
Citations	[1]Nelson J, et al. Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis. Cancer Res. 1995 Sep 1;55(17):3772-6.
Smiles	O=C(N(CCC1)[C@@H]1C(NCC(N[C@H](C(N[C@@H]([C@@H](C)CC)C(NCC(N[C@@H](CO)C(N[C@H](C(O)=O)CCCNC(N)=N)=O)=O)=O)=O)CC2=CC=C(O)C=C2)=O)=O)[C@H](CC(O)=O)NC([C@@H](N)CS)=O.OC(C(F)(F)F)=O
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Laminin (925-933) (TFA)
Shipping Condition	Cool pack
Available
Manufacturer - Type	Peptides
Manufacturer - Applications	Cancer-programmed cell death
Manufacturer - Targets	Others
Shipping Temperature	Blue Ice
Storage Conditions	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Molecular Weight	1081.08
Product Description	Laminin peptide CDPGYIGSR (Laminin (925-933)) TFA is a peptide derived from the Laminin B1 chain that binds to the laminin receptor[1].
Manufacturer - Research Area	Cancer
Solubility	H2O: 50 mg/mL (ultrasonic)
Manufacturer - Pathway	Others
Clinical information	No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-P0131A-5mg-safety-datasheet.pdf